[go: up one dir, main page]

WO2007036363A8 - Zusammensetzungen, welche buttersäureester von kohlenhydraten und kohlenhydratpolyolen enthalten - Google Patents

Zusammensetzungen, welche buttersäureester von kohlenhydraten und kohlenhydratpolyolen enthalten

Info

Publication number
WO2007036363A8
WO2007036363A8 PCT/EP2006/009436 EP2006009436W WO2007036363A8 WO 2007036363 A8 WO2007036363 A8 WO 2007036363A8 EP 2006009436 W EP2006009436 W EP 2006009436W WO 2007036363 A8 WO2007036363 A8 WO 2007036363A8
Authority
WO
WIPO (PCT)
Prior art keywords
carbohydrates
acid ester
butyric acid
compositions containing
containing butyric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2006/009436
Other languages
English (en)
French (fr)
Other versions
WO2007036363A3 (de
WO2007036363A2 (de
Inventor
Begli Alireza Haji
Michael Klingeberg
Joerg Kowalczyk
Gunhild Kozianowski
Stephan Theis
Wolfgang Wach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suedzucker AG
Original Assignee
Suedzucker AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suedzucker AG filed Critical Suedzucker AG
Priority to EP06805927A priority Critical patent/EP1931356A2/de
Priority to JP2008532674A priority patent/JP2009509999A/ja
Priority to US12/088,396 priority patent/US20080213341A1/en
Publication of WO2007036363A2 publication Critical patent/WO2007036363A2/de
Publication of WO2007036363A8 publication Critical patent/WO2007036363A8/de
Publication of WO2007036363A3 publication Critical patent/WO2007036363A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)

Abstract

Die Erfindung betrifft Buttersäureester oder Butyratester von Kohlenhydraten und Kohlenhydratpolyolen und deren Verwendung als Butyrat-Carrier und Butyratquelle für den Magen-Darm-Trakt, insbesondere zur Vorbeugung und Behandlung von Erkrankungen des Magen-Darm-Trakts, vor allem des Dickdarms.
PCT/EP2006/009436 2005-09-28 2006-09-28 Zusammensetzungen, welche buttersäureester von kohlenhydraten und kohlenhydratpolyolen enthalten Ceased WO2007036363A2 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP06805927A EP1931356A2 (de) 2005-09-28 2006-09-28 Zusammensetzungen, welche buttersäureester von kohlenhydraten und kohlenhydratpolyolen enthalten
JP2008532674A JP2009509999A (ja) 2005-09-28 2006-09-28 炭水化物および炭水化物ポリオールの酪酸エステル
US12/088,396 US20080213341A1 (en) 2005-09-28 2006-09-28 Butyric Acid Esters of Carbohydrates and Carbohydrate Polyols

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005046237A DE102005046237A1 (de) 2005-09-28 2005-09-28 Buttersäureester von Kohlenhydraten und Kohlenhydratpolyolen
DE102005046237.5 2005-09-28

Publications (3)

Publication Number Publication Date
WO2007036363A2 WO2007036363A2 (de) 2007-04-05
WO2007036363A8 true WO2007036363A8 (de) 2007-06-14
WO2007036363A3 WO2007036363A3 (de) 2007-10-11

Family

ID=37806810

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/009436 Ceased WO2007036363A2 (de) 2005-09-28 2006-09-28 Zusammensetzungen, welche buttersäureester von kohlenhydraten und kohlenhydratpolyolen enthalten

Country Status (6)

Country Link
US (1) US20080213341A1 (de)
EP (1) EP1931356A2 (de)
JP (1) JP2009509999A (de)
CN (1) CN101316598A (de)
DE (1) DE102005046237A1 (de)
WO (1) WO2007036363A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20040187A1 (it) * 2004-02-06 2004-05-06 Cosmo Spa Composizioni farmaceutiche o dietetiche a base di acidi grassi a catena corta e zuccheri complessi per le disfunzioni intestinali
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
US20090297660A1 (en) * 2008-06-02 2009-12-03 Kraft Food Holdings, Inc. Cheese Products Containing Galacto-Oligosaccharides And Having Reduced Lactose Levels
HRP20170886T1 (hr) 2009-01-12 2017-09-08 Biokier Inc. Smjesa i metoda za liječenje dijabetesa
US9314444B2 (en) 2009-01-12 2016-04-19 Biokier, Inc. Composition and method for treatment of NASH
US9006288B2 (en) 2009-01-12 2015-04-14 Biokier, Inc. Composition and method for treatment of diabetes
CA2752800C (en) 2009-02-24 2017-12-05 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
CN101647516A (zh) * 2009-06-17 2010-02-17 新奥（厦门）农牧发展有限公司 丁酸盐或丁酸甘油脂与膳食纤维的复合物及其制法和在饲料添加剂中的应用
CN101647517A (zh) * 2009-06-17 2010-02-17 新奥（厦门）农牧发展有限公司 丁酸盐或丁酸甘油脂与低聚果糖的复合物及其制法和在饲料添加剂中的应用
MX2012003459A (es) 2009-09-23 2012-05-22 Biokier Inc Composicion y metodo para el tratamiento de la diabetes.
CA2790097A1 (en) * 2010-03-05 2011-09-09 Ophthalmopharma Ag Nutraceutical chocolate or compound chocolate product
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
IT1401309B1 (it) * 2010-08-03 2013-07-18 Cosmo Technologies Ltd Pharmaceuticals and/or dietary compositions based on short chain fatty acids. composizioni farmaceutiche e/o dietetiche a base di acidi grassi a corta catena.
WO2012013495A1 (en) * 2010-07-29 2012-02-02 Cosmo Technologies Ltd. Pharmaceutical and/or dietary compositions based on short chain fatty acids
GB201213629D0 (en) 2012-07-31 2012-09-12 Imp Innovations Ltd Compounds and their effects on appetite control and insulin sensitivity
WO2015084158A1 (en) * 2013-12-06 2015-06-11 N.V. Nutricia A pyrimidine derivative and a fatty acid source for use in the treatment of constipation
BE1023491B1 (nl) * 2015-10-06 2017-04-06 Nutri-Ad International Nv Voedingsadditief voor gevogelte
US20170127693A1 (en) * 2015-11-09 2017-05-11 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US10034937B2 (en) 2015-12-04 2018-07-31 Mead Johnson Nutrition Company Synergistic nutritional compositions and uses thereof
EP3496708B1 (de) * 2016-08-10 2025-03-26 Monash University Metaboliten zur behandlung und prävention von autoimmunerkrankungen
JP2018158895A (ja) * 2017-03-22 2018-10-11 株式会社ダイセル 制御性ｔ細胞増加剤、食品、及び医薬
SG11201910198UA (en) * 2017-06-05 2019-11-28 Flagship Pioneering Innovations V Inc Multibiotic agents and methods of using the same
KR102082315B1 (ko) * 2018-05-08 2020-02-27 주식회사 비피도 부티릴 프락토올리고당을 포함하는 프리바이오틱스 조성물
EP3801489A4 (de) 2018-06-05 2022-03-30 Flagship Pioneering Innovations V, Inc. Acylierte wirkstoffe und verfahren zu deren verwendung zur behandlung von autoimmunerkrankungen
CN109504713B (zh) * 2018-12-04 2022-05-17 齐鲁工业大学 利用拜氏梭菌制备高酯键腐植酸制剂的方法及应用
US20230115476A1 (en) * 2019-12-05 2023-04-13 Societe Des Produits Nestle S.A. Dietary butyrate and its uses
JP7627109B2 (ja) * 2020-12-01 2025-02-05 サンエイ糖化株式会社 コラーゲン類吸収促進剤
KR102696109B1 (ko) * 2021-10-06 2024-08-16 국립부경대학교 산학협력단 락토코커스 락티스 생육 촉진용 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3579547A (en) * 1966-12-16 1971-05-18 Scm Corp Carboxylic acid esters
JPS5089314A (de) * 1973-12-14 1975-07-17
JPS61268192A (ja) * 1985-05-24 1986-11-27 Meito Sangyo Kk 糖類脂肪酸エステル化合物の製造法
US4959975A (en) * 1987-05-14 1990-10-02 Conserve, Inc. Heat pump system
FR2633929B2 (fr) * 1987-09-25 1995-05-24 Picardie Universite Derives non toxiques de l'acide n-butyrique, presentant des actions therapeutiques retardees
US4959466A (en) * 1988-01-25 1990-09-25 Arco Chemical Technology, Inc. Partially esterified polysaccharide (PEP) fat substitutes
WO1995009145A1 (en) * 1993-09-30 1995-04-06 Eastman Chemical Company NUTRITIVE GLYCEROL ESTERS OF β-ACYLOXY BUTYRATES
DE4414138A1 (de) * 1994-04-22 1995-10-26 Consortium Elektrochem Ind Acylierte gamma-Cyclodextrine
FR2723096B1 (fr) * 1994-07-28 1996-10-18 Univ Picardie Esters associant les acides phenylacetique,3-phenyl-propionique, 4-phenyl-butyrique et n-butyrique au d-mannose, au xylitol et a leurs derives. applications comme medicaments
US5569680A (en) * 1995-02-13 1996-10-29 Trustees Of The Univ. Of Penna Method of treating inflammatory bowel disease with tributyrin
US5763488A (en) * 1995-10-30 1998-06-09 Vertex Pharmaceuticals Incorporated Methods and compositions using butyrate esters of threitol
IT1286510B1 (it) * 1996-11-29 1998-07-15 Cooperativa Centro Ricerche Po Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono
CA2417840A1 (en) * 2000-08-02 2002-02-07 Atossa Healthcare, Inc. Bimodal emulsions of taxanes and butyrate polyalcohol esters
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
DE10328180A1 (de) * 2003-06-16 2005-01-13 Südzucker AG Mannheim/Ochsenfurt Verwendung von Isomalt als Präbiotikum
US20060105962A1 (en) * 2004-11-14 2006-05-18 Robinson Robert O A Tonic to maintain intestinal flora

Also Published As

Publication number Publication date
WO2007036363A3 (de) 2007-10-11
JP2009509999A (ja) 2009-03-12
CN101316598A (zh) 2008-12-03
WO2007036363A2 (de) 2007-04-05
US20080213341A1 (en) 2008-09-04
EP1931356A2 (de) 2008-06-18
DE102005046237A1 (de) 2007-04-05

Similar Documents

Publication Publication Date Title
WO2007036363A8 (de) Zusammensetzungen, welche buttersäureester von kohlenhydraten und kohlenhydratpolyolen enthalten
WO2007087231A3 (en) Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
WO2007126745A3 (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
WO2007097931A3 (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
WO2007136603A3 (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
WO2006127530A3 (en) Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
WO2008042688A3 (en) Phlorizin analogs as inhibitors of sodium glucose co-transporter 2
WO2009123720A3 (en) Methods and compositions for medical articles produced from proteinaceous compounds
GEP20135724B (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for treatment or prevention of diabetes
WO2007011833A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
WO2007064883A3 (en) Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
WO2007008529A3 (en) Celullar cholesterol absorption modifiers
MY147247A (en) Organic compounds and their uses
WO2008030412A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
WO2007024993A3 (en) Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
UA95464C2 (en) Pyridopyrazine derivatives and use thereof
WO2007123939A3 (en) Novel arylamino n-heteraryls as mek inhibitors
WO2008066784A3 (en) Expression of foxp3 by cancer cells
WO2008054698A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
WO2008136865A3 (en) (s)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs
WO2008073332A3 (en) Creatine compositions for skin treatment
IL193252A0 (en) N-hydroxyacrylamide compounds
WO2007144057A3 (en) Antimicrobial carbon
WO2005077462A3 (en) Cd70 inhibition for the treatment and prevention of inflammatory bowel disease
WO2007019078A3 (en) Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200680044065.X

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2006805927

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2008532674

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 12088396

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2006805927

Country of ref document: EP